Ofev (nintedanib) receives positive recommendation from CADTH and INESSS for the treatment of progressive fibrosing interstitial lung diseases

4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...

Read more →

AbbVie’s Skyrizi for the treatment of moderate to severe plaque psoriasis now publicly reimbursed across Canada

24 February 2021 - Prince Edward Island lists Skyrizi on its Pharmacare Formulary effective 22 February 2021. ...

Read more →

Ontario makes commitment to funding CF drugs after approval process completed

19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...

Read more →

Fresenius Kabi Canada launches Idacio (adalimumab injection) a biosimilar to Humira (adalimumab) for the treatment of multiple chronic inflammatory conditions

18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...

Read more →

HLS Therapeutics provides update on private and public payer reimbursement for Vascepa

16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...

Read more →

Manitoba is Canada’s first province to nab home grown vaccine

12 February 2021 - Manitoba to buy 2 million doses of yet to be approved vaccine. ...

Read more →

An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency

9 February 2021 - The practice of public and patient engagement in health technology assessment has spread worldwide, yet gaps in ...

Read more →

Cystic fibrosis advocate asks P.E.I. to fast-track coverage of new 'mind-blowing' drug

10 February 2021 - ‘It’s the closest thing we’ve ever had to a cure’. ...

Read more →

New drugs entering Canada at steady rate over past 5 years - Canada still among top 10 OECD countries in terms of access to new drugs

10 February 2021 - The latest edition of the Patented Medicine Prices Review Board Meds Entry Watch reports that 40 new-to-Canada ...

Read more →

Patient and public involvement in health technology assessment: update of a systematic review of international experiences

5 February 2021 - This paper summarises the current evidence on patient and public involvement in health technology assessment  in order ...

Read more →

Alberta announces funding for pricey gene therapy drug Zolgensma

Alberta Health Minister Tyler Shandro announced funding Wednesday for the gene therapy Zolgensma, which is used to treat toddlers with ...

Read more →

Will Canadians get to choose which COVID-19 vaccine they get?

26 January 2021 - Two vaccines are already approved, two are under review, and two more are in the pipeline, ...

Read more →

Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health

22 January 2021 - In recognition of patients’ roles using, and contributing to, a publicly funded health system, the Canadian Agency ...

Read more →

Canada’s drug makers rattle their sabers over a government plan to control medicine spending

21 January 2021 - A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug spending ...

Read more →

Industry pooling helps maintain affordability of high cost drugs despite significant inflationary pressures

21 January 2021 - In 2019, the Canadian Drug Insurance Pooling Corporation's (CDIPC) high-cost drug sharing framework provided coverage to ...

Read more →